Category: Mass Tort

Irbesartan, and Losartan, that contained the active ingredient Valsartan could contain a cancer causing agent known as NDMA (Nitrosodimethylamine).

If you took Valsartan or a generic blood pressure medication, such as Irbesartan or Losartan, during the past 3 – 4 years for 12 months or longer and then developed Cancer you may be eligible for compensation.

In July 2018, the FDA issued a Valsartan recall. If you took Valsartan or a Valsartan generic blood pressure medication, such as Irbesartan or Losartan, during the past 3 – 4 years for 12 months or longer and then developed Cancer you may be eligible for compensation. The blood pressure medications such as Valsartan, Irbesartan, and Losartan, that contained the active ingredient Valsartan could contain a cancer causing agent known as NDMA (Nitrosodimethylamine).

According to CDC health statement exposure:

“HOW CAN N-NITROSODIMETHYLAMINE AFFECT MY HEALTH? NDMA is very harmful to the liver of animals and humans. People who were intentionally poisoned on one or several occasions with unknown levels of NDMA in beverage or food died of severe liver damage accompanied by internal bleeding. Animals that ate food, drank water, or breathed air containing high levels of NDMA over a period of days or several weeks also developed serious, non-cancerous, liver disease. When rats, mice, hamsters, and other animals ate food, drank water, or breathed air containing lower levels of NDMA for periods more than several weeks, liver cancer and lung cancer as well non-cancerous liver damage occurred. The high level short term and low level long-term exposures that caused non-cancerous liver damage and/or cancer in animals also usually resulted in internal bleeding and death. Although there are no reports of NDMA causing cancer in humans, it is reasonable to expect that exposure to NDMA by eating, drinking, or breathing could cause cancer in humans. Mice that were fed NDMA during pregnancy had offspring that were born dead or died shortly after birth. However, it is not known whether NDMA could cause the death of human babies whose mothers are exposed during pregnancy. It should be realized that exposure to NDMA does not mean that any effect on health will definitely occur.” 

This contaminated medication that contains NDMA has been linked to liver damage (fibrosis, scarring, abnormal liver function tests) along with kidney and liver tumors – both malignant and benign. The longer period of time one consumed the contaminated blood pressure medication, the more likely the user is to develop these chronic or catastrophic injuries.

If you or a loved one took Valsartan, Irbesartan or Losartan during the past 3-4 years for 12 months or more and have developed liver damage or cancer, you may be entitled to compensation.  Call Now for Your Free No Obligation Consultation toll free: 1888-TheLawyer (1888-843-5299 toll free)

Investors Sue Johnson & Johnson for Losses

Investors Sue Johnson & Johnson for Losses

Johnson & Johnson officials may already be wondering if past profits from its nearly ubiquitous Baby Powder will pay for the ongoing losses from lawsuits brought by cancer patients or their living relatives.

The company has faced thousands of lawsuits from women and/or their relatives after victims contracted ovarian cancer. Medical studies have shown that talc-containing personal hygiene products, such as Johnson & Johnson Baby Powder, can increase the risk of ovarian cancer as much as 30 percent for women who used the product in their genital area.
Talc particles can make their way through the reproductive system and land in the ovaries, where they can grow into cancerous tumors.

Juries have awarded hundreds of millions of dollars in verdicts to cancer victims across the country who sued Johnson & Johnson after contracting ovarian cancer.

Another line of litigation that has begun in recent months involves asbestos-contaminated talc. Documents revealed in trials showed that Johnson & Johnson and other companies knew for many years several talc mines had been contaminated with asbestos.
In those cases, victims contracted cancers such as mesothelioma after being exposed to talc-containing products.
Mesothelioma is an aggressive and deadly cancer that usually comes from inhaled or ingested asbestos fibers. The fibers attach to the lining of internal organs such as the lungs or heart and become cancerous, sometimes after many years of dormancy.

Asbestos, now restricted, was a common building material because of its sturdiness and fire-resistant qualities. It was used in concrete, ceiling and floor tiles, insulation and various automotive parts such as brake pads and gaskets.

Until the industry documents came to light, mesothelioma cases involving people who had been exposed to talc-containing products but not asbestos-containing materials didn’t fit normal patterns. Now, many cancer victims can understand where their cancer came from and who is responsible for it.
As if those lines of liability weren’t enough, Johnson & Johnson is now facing a third threat — investor lawsuits.
A Bloomberg story written by Jennifer Bennett notes that an investor class-action suit against Johnson & Johnson contends the investors lost money because of the revelations the company knew of the risks posed by its products but did nothing to alert the public or change the elements of its products. The suit has been filed in federal court in New Jersey.
According to the story, the investors claim “the company misled them about the decades-old link, repeatedly saying its talc products were asbestos-free and safe.” Negative media coverage coming from lawsuits against the company have led to stock price declines.
A spokesman for Johnson & Johnson dismissed the case as “baseless.”
“Johnson’s Baby Powder does not contain asbestos or cause mesothelioma or ovarian cancer, and we are confident that our talc products are, and always have been, free of asbestos, based on decades of monitoring, testing and regulation dating back to the 1970s,” Knewitz said. “Sample testing by independent laboratories, independent scientists, governmental agencies and academic institutions spanning decades have all confirmed the absence of asbestos in our talc products.”

hip replacement implant

FDA Holds Metal-on-Metal Hip Replacement System Makers Accountable

Federal regulators have taken numerous steps to ensure that manufacturers providing metal-on-metal hip replacement systems are following stringent guidelines and adhering to several reporting procedures.

These steps come in the wake of thousands of failures of metal-on-metal hip replacement systems, such as the Pinnacle system made by DePuy Orthopaedics, a subsidiary of Johnson & Johnson.

There is lots of buzz around the Depuy Hip Replacement Lawsuit

Metal-on-metal hip replacement systems use a metal ball and joint, rather than a plastic or ceramic joint. However, these systems have failed at a higher than normal rate, requiring revision surgery or surgeries and causing other problems, such as irritation at the implantation site. Another problem has been the heavy metal shavings that can lead to bleeding at the implant site or leech into the patient’s bloodstream. This condition is called “metallosis.”

Metal-on-metal hip replacement systems use cobalt and chromium, both of which can cause various health issues and have been linked in medical research to depression and symptoms of dementia.

The U.S. Food and Drug Administration has ordered metal-on-metal hip replacement system manufacturers to submit premarket approval applications, which allows FDA officials to review the design, testing and production of the systems before they are available for use.

DePuy hip replacement lawsuit.

According to court documents, DePuy Orthopaedics had design, testing and production flaws with some of its metal-on-metal hip replacement systems. Juries have awarded hundreds of millions of dollars in damages to patients whose systems failed

The FDA premarket approval application will require manufacturers to address any risks known, or that should reasonably be known; the effectiveness of the device; full reports from investigations on the safety and effectiveness of the device.

Regarding metal-on-metal hip replacement systems, FDA has also taken steps to:

• evaluate such devices using magnetic resonance imaging (MRI);

• support new technologies to improve imaging around metal implants to better locate problems before they become serious;

• encourage metal ion testing procedures to ensure consistent practices and reporting;

• review literature regarding devices and results in the United States and around the world;

• review reports involving failed devices to determine why and how the device failed;

• direct manufacturers to conduct a postmarket surveillance study to gather “additional information about the safety profiles of the implants, including the effect of metal ion concentrations in the bloodstream”;

• organize orthopaedic registries around the world to more consistently report and catalogue issues with the devices; and

• provide safety information to patients and health care providers.

That’s not all!
In 2005, J&J pushed their DePuy ASR Hip implants in the United States as a new design that would last 20 years and would provide a greater range of motion. The DePuy ASR metal on metal hip implant design has a metal femur head that rotates within a metal cup, known as a metal on metal design. According to the FDA metal on metal (MoM) Hip Implant Systems consist of a metal ball, metal stem and a metal shell. These metal on metal hip implants were designed to have less device wear, decreased chance of dislocation, and decreased chance of fracture.
However, the metal ball and the metal cup slide against each other during movement causing metal particles to be released. Over time, the metal particles can cause damage to bone and/or tissue surrounding the implant and joint. Soft tissue damage may lead to pain, implant loosening, implant failure, and/or revision surgery. –authored by Rick Fahr

Johnson & Johnson Target of Talc Powder Caused Ovarian Cancer

As Americans begin to learn more about the dangers of talc, more of them are using the court system to hold accountable companies whose products contain the mineral.

A new case has been brought against Johnson & Johnson in Los Angeles County. The plaintiff is a man whose wife died of ovarian cancer. The woman used Johnson & Johnson Baby Powder and Shower to Shower powder, both feminine hygiene products.

This new filing comes on the heels of a recent jury finding in St. Louis that the family of a woman who died from ovarian cancer after using talc-containing feminine hygiene products was entitled to $72 million in damages.
According to court documents, Soren Threadgill contends that his wife, Eva Maria, used the talc-containing products for 25 years. Doctors diagnosed her with ovarian cancer in 1998, and she died four years later.

His suit contends that Johnson & Johnson; Imerys Talc America, Johnson & Johnson’s main talc supplier; and the stores where the products were purchased, Rite Aid Corp. and Gelson’s, a supermarket chain, are liable for her wrongful death. The suit also alleges fraud, negligence, breach of implied warranty and product liability.

As in more than 1,000 cases across the country, Eva Maria Threadgill used the talc-containing products on a daily basis. Research has shown that talc particles from the powders make their way through the female genital area, ultimately settling in the ovaries, where they lead to a significant cancer risk.

Johnson & Johnson marketing efforts over the past several decades show that the company intended for its products to be used regularly — “Just a sprinkle a day keeps the odor away,” one ad slogan reads, according to Threadgill’s complaint. Another slogan encourages women to use the products “ anytime you want the skin to feel soft, fresh and comfortable.”

However, leading cancer researchers have linked talc to cancer for many years. In 1994, the Cancer Prevention Coalition warned Johnson & Johnson that females who use talc-containing products in their genital area are at “a serious risk of ovarian cancer,” Threadgill’s suit notes. Also in the suit is the fact that the International Association for the Research of Cancer labeled as a human carcinogen hygiene powders that contain talc.

To date, Johnson & Johnson has refused to include a warning label of the cancer risk on any of its products that include talc. The company has earned special scorn for its marketing efforts toward African-American females, who use body powders at a higher rate than the female population in general.